Arkolith/Insider Trading/TLSI/Form 4

Szela Mary T

CEO and President, DirectorTriSalus Life Sciences, Inc. (TLSI) · full profile →Form 4 · filed Mar 20, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$79K
Net Open-Market Flow
-$79K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 17, 2026Sell(S)16K$3.85$61K753K
Mar 11, 2026Sell(S)4K$4.13$18K769K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-020186) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML